nei THIS MONTH IN
PSYCHOPHARMACOLOGY
Browsing articles in "Anxiety/Stress-Related Disorders"

 

Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus
April 9, 2020   

With the rising rates of COVID-19 (i.e., severe acute respiratory syndrome coronavirus 2) infection and hospitalization across the world, frontline health care workers will continue to face an overwhelming workload throughout the course of this pandemic. This workload, along with the depletion of personal protection equipment, widespread media coverage, lack of specific drugs and feelings of being inadequately supported may contribute to adverse psychological reactions...
 Continue reading
FDA Bans Electrical Stimulation Devices for Self-Injurious or Aggressive Behavior
March 23, 2020   

The U.S. Food and Drug Administration (FDA) bans electrical stimulation devices used for self-injurious or aggressive behavior because they present...
 Continue reading (Members only)
Severe Clinical Consequences of Childhood Abuse and Neglect
February 10, 2020   

l infarction, cerebrovascular disease, type 2 diabetes, asthma, cancer, and overall lowered life expectancy. In this article, the authors review the current state of research regarding the association of early childhood abuse/neglect with development of psychiatric illness, particularly mood disorders such as...
 Continue reading (Members only)
Meta-analysis Shows No Effect of Omega-3 for Prevention or Treatment of Depression and Anxiety
November 25, 2019   

Many individuals suffering from mental health disorders, such as depression and anxiety, turn to the use of complementary and alternative medications (CAMs). One such CAM is polyunsaturated fatty acids...
 Continue reading (Members only)
FDA Approves New Cranial Electrotherapy Stimulator—Integrated Into a Stereo Headset
April 11, 2019   

The Food and Drug Administration (FDA) has approved a new cranial electrotherapy stimulator for treatment of anxiety, depression, and insomnia. The device, Cervella, is operated using...
 Continue reading (Members only)
Risk of PTSD and Major Depression After Mild Traumatic Brain Injury
March 25, 2019   

A prospective cohort study was recently conducted to examine the relationship between mild traumatic brain injury (mTBI) and comorbid mental health conditions. The study included 1155 patients with mTBI and 230 patients with orthopedic injuries not involving the head. Patients with mTBI were more likely to...
 Continue reading (Members only)
MDMA for the Treatment of PTSD
August 27, 2018   

Although still investigational, the psychogenic compound 3,4-methylenedioxymethamphetamine (MDMA) -administered in conjunction with psychotherapy- has shown long-lasting benefit to patients suffering with PTSD....
 Continue reading (Members only)
Repetitive Transcranial Magnetic Stimulation in US Veterans With Treatment-Resistant Depression
July 21, 2018   

A recent study examined the effect of repetitive transcranial magnetic stimulation on US veterans with treatment-resistant major depression...
 Continue reading (Members only)
Novel Approach to Treating Posttraumatic Stress Disorder
June 27, 2018   

A novel approach to the treatment of combat-related post-traumatic stress disorder (cr-PTSD) could play a significant role in helping British veterans overcome PTSD, a new Cardiff University research project suggests...
 Continue reading
Proposed ICD-11 PTSD Criteria May Lead to Missed Diagnoses
June 5, 2018   

A recent study examined whether changes to post-traumatic stress disorder (PTSD) diagnostic criteria in the upcoming International Classification of Diseases (ICD)-11 may affect the prevalence and identification of PTSD cases...
 Continue reading (Members only)
123
Top of Page